Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
The Best Cell phone Brands for Tech Aficionados - 2Manual for 6 Busssiness Class Flights
- 3Thousands of ultra-orthodox protest in Jerusalem against conscription
- 4Mossad unveils network of Hamas terror infrastructure across Europe
- 5Google's proposed data center in orbit will face issues with space debris in an already crowded orbit
- 'Israel has the right to continue its attacks,' Lebanese Foreign Minister announces
- Bomb blast in packed Nigerian mosque kills five
- Careful Connections: Building Association and Trust
- French lawmakers narrowly approve health care budget, suspending Macron's flagship pension reform
- Five held on suspicion of planning attack on German Christmas market
- Timothy Busfield turns himself in to face child sexual abuse charges in New Mexico
- Most loved Occasion Dish: What Makes Your Merry Table?
- The best overlooked performances of 2025
- In these U.S. groups, deaths now exceed births. What’s happening?
